Cefaclor Recommended Dosing
For adults, cefaclor is dosed at 250 mg orally every 8 hours for mild infections, doubling to 500 mg every 8 hours for more severe infections or less susceptible organisms; for children, the standard dose is 20 mg/kg/day divided every 8 hours, increasing to 40 mg/kg/day (maximum 1 g/day) for more serious infections including otitis media. 1
Adult Dosing
- Standard dose: 250 mg orally every 8 hours for routine susceptible infections 1
- Severe infections: 500 mg orally every 8 hours for pneumonia or infections caused by less susceptible organisms 1
- The medication should be administered orally, and absorption is delayed when taken with food 2
Pediatric Dosing
Standard Dosing (20 mg/kg/day)
- 20 mg/kg/day divided every 8 hours for routine infections including pharyngitis and mild soft tissue infections 1
- For a 9 kg child: 2.5 mL (½ teaspoon) of 125 mg/5 mL suspension three times daily 1
- For an 18 kg child: 5 mL (1 teaspoon) of 125 mg/5 mL suspension three times daily, or 2.5 mL of 250 mg/5 mL suspension three times daily 1
Higher Dosing (40 mg/kg/day)
- 40 mg/kg/day divided every 8 hours for more serious infections, otitis media, and infections caused by less susceptible organisms 1
- Maximum daily dose: 1 gram per day regardless of weight 1
- For a 9 kg child: 5 mL (1 teaspoon) of 125 mg/5 mL suspension three times daily, or 2.5 mL of 250 mg/5 mL suspension three times daily 1
- For an 18 kg child: 5 mL (1 teaspoon) of 250 mg/5 mL suspension three times daily 1
Alternative Twice-Daily Dosing
- For otitis media and pharyngitis only, the total daily dose may be divided and given every 12 hours instead of every 8 hours 1
- This provides a more convenient dosing schedule while maintaining efficacy for these specific infections 1
Clinical Applications
Demonstrated Efficacy
- Urinary tract infections in adults and children 2
- Upper and lower respiratory tract infections 2
- Skin and soft tissue infections with 90% favorable clinical and bacteriological responses 3
- Pediatric otitis media 2
- Streptococcal pharyngitis with superior bacteriologic eradication compared to penicillin V (96.6% vs 80.4% success rate) 4
Spectrum of Activity
- Active against beta-lactamase-producing Haemophilus influenzae resistant to ampicillin 2, 3
- Covers Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes 3
- More susceptible organisms include Escherichia coli, Klebsiella spp., Proteus mirabilis, and Salmonella spp. compared to cephalexin 2
Important Clinical Considerations
Duration of Therapy
- Minimum 10 days for beta-hemolytic streptococcal infections to prevent rheumatic fever 1
- Standard course is 5-10 days for most other infections 5
Renal Impairment
- Cefaclor may be administered without dosage adjustment in patients with impaired renal function, as elimination is primarily renal but the standard dose remains unchanged 1
Safety Profile
- Adverse reactions are mostly gastrointestinal, generally mild, and occur infrequently (approximately 5% of patients) 5
- Hepatic, renal, and hematopoietic studies show minimal adverse effects except occasional eosinophilia without clinical hypersensitivity 3